Navigation Links
XBiotech Announces Incorporation Of Its Wholly Owned Subsidiary XBiotech Japan KK
Date:3/26/2013

AUSTIN, Texas, March 26, 2013 /PRNewswire/ -- XBiotech, a privately held biotechnology company, announced the incorporation of its wholly owned Japanese subsidiary, XBiotech Japan KK. The creation of the Japanese Company is reportedly the first step in XBiotech's strategy to expand its clinical operations and ultimately product reach into the unique Japanese market place.

"XBiotech is committed to availing its drug development technologies to serve unmet medical need in Japan," said Erika Geimonen, Vice President of Business Development, XBiotech. "This is a very special market place and we look forward to working with the PMDA and our Japanese partners to help patients access important therapies. Whether we are talking about our True Human™ antibody therapies, or biosimilars, we offer the possibility of breakthrough with respect to how biological drugs can be used to help sustain Japanese patients and the Japanese healthcare system alike."

XBiotech's production technology is enabling unprecedented cost efficiencies. Making proprietary True Human™ biologics affordable will help enable access to new and larger markets, and promises to set a new bar for drug pricing. Yet, dramatic cost reductions for biosimilar drugs could be game changing—and permit very aggressive competition for market share for existing world-leading biological drug products. Hence, XBiotech has recently expanded its pipeline with the development of biosimilars.

About XBiotech
The Company has developed simple, minimal infrastructure production technology, dramatically reducing capital requirements and lead times, while greatly improving regulatory compliance and production flexibility. These processes are now a cornerstone of XBiotech's commercialization platform. The Company is now equipped with know how and technology to produce the most affordable biological drug products in the world
'/>"/>

SOURCE XBiotech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
2. XBiotech Expands Portfolio to Include Biosimilars
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
7. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
8. WuXi PharmaTech Announces Third-Quarter 2011 Results
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Spherix Announces Third Quarter Financial Results
11. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 A major challenge before ... start-up dense realm of Boston-Cambridge, is gaining visibility that ... James Sherley, the Director of Boston’s Adult Stem Cell ... and national visibility of his company an important priority ... In addition to a social media marketing campaign ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 “This kit has ... to screen from 0 to 150 ppb,” said Mark Tess, ... a significant benefit to plant owners and USDA-GIPSA inspection agencies ... other commodities. Testing can take place in a matter of ... can the plant test the feed and grain before accepting ...
(Date:8/28/2014)... 28, 2014  Next month, executives from clinical trial marketing ... events beginning with Patient-Centered Clinical Trials 2014 , to ... Boston , September 4-5. Patient recruitment experts Bonnie ... Fleishman will share insights on the benefits of employing ... tactics – from media to mobile apps – can be ...
(Date:8/28/2014)... 2014 Scientists, researchers, and technologists will ... Laser Damage 2014 symposium. Marking its 46th year, ... will run 14-17 September. The event is sponsored by ... . , The premier conference for basic and applied ... optical materials will engage researchers and engineers from numerous ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3
... ... based on the Altera Stratix® IV 820 devices. These contain the largest FPGA on ... , ... 16, 2010 -- IRIS Technologies Inc. ( www.iris-technologies.net ) has released two new ...
... , ... Writers Association Recognizes Buckley/Swartz , ... Boston, MA (PRWEB) June 16, 2010 -- The American Medical Writers Association ... recipient of two Will Solimene Awards for Excellence in Medical Communication. She received the ...
... This release is avaiable in French ... range of high-tech products such as computer displays or ... ordered chemical composition as inorganic materials, preventing scientists from ... team of researchers led by McGill,s Dr. Dmitrii Perepichka ...
Cached Biology Technology:IRIS Technologies Inc. Launches Two New Stratix IV FPGA-Based Boards 2IRIS Technologies Inc. Launches Two New Stratix IV FPGA-Based Boards 3Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication 2Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication 3Organic nanoelectronics a step closer 2
(Date:8/28/2014)... your neighbors than traditional cigarettes, but still release ... study from USC. , Scientists studying secondhand smoke ... exposure to harmful particles, with close-to-zero exposure to ... harmful metals in second-hand e-cigarette smoke were found ... contains high levels of polycyclic aromatic hydrocarbons ...
(Date:8/28/2014)... groups and clinicians is critical to the development ... of Georgia research. , A qualitative study of ... that role models for successful breastfeeding help positively ... "Mothers who received that support are more likely ... Alex Anderson, an associate professor in the College ...
(Date:8/28/2014)... Energy production systems are good examples of complex ... like a networkincluding water for cooling, transport to ... management. Every step in the network chain is ... all mutually dependent. A team of UK-based scientists ... previously explored. The findings have been published in ...
Breaking Biology News(10 mins):Second-hand e-cig smoke compared to regular cigarette smoke 2Breastfeeding study shows need for effective peer counseling programs 2Inter-dependent networks stress test 2
... melanin in their skin cells provides protection from the damage ... have shown that melanin, which is produced by multitudes of ... ionizing radiation. In certain microbes, in particular some organisms ... has even been linked to increased growth in the presence ...
... Virginia Bioinformatics Institute (VBI) at Virginia Tech will ... (HPC) company Convey Computer as part of a ... "This partnership will usher in a paradigm shift ... using Convey,s hybrid-core platform and relevant technologies," said ...
... A new study of children,s hospitals nationwide has found ... the event of a pandemic, and urges health care institutions ... flu season approaches. "Every year we get lucky," said ... professor of pediatrics at the University of Colorado School of ...
Cached Biology News:Melanin's 'trick' for maintaining radioprotection studied 2VBI, Convey Computer partner to deliver technology to biomedical, life sciences researchers 2Children's hospitals not equipped to handle pandemics 2
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
... Explorer processes up to 48 lanes, 24 ... input can be from either slab gel ... primer chemistries. The detection parameters in Explorer ... analyst consistency. We have built Explorer ...
... Quality ISO 9001:2000 Certified USDA ... Precedures Validated, SOP's Training AALAS ... for All Procedures GLP Documentation Upon Request ... stop shopping point for all your custom ...
...
Biology Products: